The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2016

Filed:

Sep. 29, 2015
Applicant:

Zyomed Corp., Altadena, CA (US);

Inventors:

Sandeep Gulati, La Canada, CA (US);

Timothy L. Ruchti, Gurnee, IL (US);

William V. Antwerp, Valencia, CA (US);

John L. Smith, Portland, OR (US);

Assignee:

Zyomed Corp., Altadena, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01J 5/02 (2006.01); G01N 21/3577 (2014.01); A61B 5/024 (2006.01); G01N 21/359 (2014.01); G01N 21/47 (2006.01); G01N 21/49 (2006.01); G01N 33/49 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 5/1455 (2006.01); A61B 5/1495 (2006.01);
U.S. Cl.
CPC ...
G01N 21/3577 (2013.01); A61B 5/0075 (2013.01); A61B 5/024 (2013.01); A61B 5/02416 (2013.01); A61B 5/1455 (2013.01); A61B 5/1495 (2013.01); A61B 5/14532 (2013.01); A61B 5/7203 (2013.01); A61B 5/7235 (2013.01); A61B 5/7264 (2013.01); G01N 21/359 (2013.01); G01N 21/4795 (2013.01); G01N 21/49 (2013.01); G01N 33/49 (2013.01); A61B 5/7253 (2013.01); A61B 5/7267 (2013.01); A61B 2560/0223 (2013.01); G01N 2201/062 (2013.01); G01N 2201/12 (2013.01); G01N 2201/129 (2013.01);
Abstract

In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.


Find Patent Forward Citations

Loading…